![]() |
|
|
Vol. 299, Issue 1, 392-398, October 2001
Department of Biopharmaceutical Sciences (Y.S., C.L.B., L.M.M., B.F., K.M.G.) and Division of Clinical Pharmacology and Experimental Therapeutics (Y.S., K.M.G.), University of California San Francisco, San Francisco, California
| |
Abstract |
|---|
|
|
|---|
Organic cation transporters (OCT1-3) play an important role in renal elimination of many drugs. The goals of this study were to 1) identify a cell culture model which constitutively expressed OCT2 that could be used to study the characteristics and regulation of this transporter, and 2) to study the mechanisms by which xenobiotics and hormones regulate the activity of OCT2. We characterized the endogenous organic cation transporter (OCT) activity in Madin-Darby canine kidney (MDCK) cells. The activity was localized to the basolateral membrane and was pH and membrane potential-dependent. The uptake of the model organic cation, tetraethylammonium, was saturable (Km, 19.5 ± 4.6 µM; Vmax, 350 ± 19.4 pmol/mg of protein/10 min) and was inhibited by known OCT inhibitors (e.g., cimetidine and quinidine). A cDNA fragment (711 base pairs) isolated by reverse transcriptase-polymerase chain reaction (RT-PCR) was greater than 83% identical to OCT2 cDNAs from mammalian species; no OCT1 or OCT3 was detected by RT-PCR, suggesting that OCT2 may be the primary basolateral OCT in MDCK. OCT2 mRNA levels were increased significantly following exposure of MDCK to the steroid hormones, dexamethasone (2.0-fold), hydrocortisone (2.4-fold), and testosterone (1.8-fold) with comparable increases in activity. Other compounds tested, including the cytochrome P450 inducers, rifampicin, phenobarbital, and phenytoin, and the OCT substrates, verapamil and metformin, had no inducing effects. Collectively, these data indicate that MDCK can serve as a useful and convenient tool in screening candidate drugs for interaction with OCT2 and for studying the regulation of this transporter. Furthermore, our data demonstrate that steroid hormones induce the transcription of OCT2 in the kidney.
| |
Introduction |
|---|
|
|
|---|
Under
physiological pH, many clinically used drugs such as antihistamines,
antiarrhythmics, antibiotics,
-adrenoceptor blocking agents,
cytostatics, and sedatives are organic cations. Although structurally
diverse, these compounds are secreted across renal epithelia via common
active transport mechanisms that have been proposed as a two-step
process: an electrogenic facilitated diffusion step via organic cation
transporters (OCTs) at the basolateral membrane and an organic
cation-proton exchange mechanism at the apical membrane that may be
mediated by OCTN2 (Pritchard and Miller, 1993
; Zhang et al., 1998a
;
Dresser et al., 2001
). In recent years, significant progress has been
made in understanding the molecular and cellular characteristics of the
OCT group. Presently, three members of the OCT group, OCT1, OCT2, and
OCT3, have been cloned from various species and functionally
characterized in heterologous expression systems (Zhang et al., 1998a
;
Koepsell et al., 1999
; Burckhardt and Wolff, 2000
; Dresser et al.,
2001
).
Xenobiotics frequently regulate proteins involved in their disposition
or detoxification. These proteins are also often under the regulatory
influence of endogenous hormones. Although there are a number of
examples of such regulation by xenobiotics or hormones, most of these
concern drug-metabolizing enzymes, most notably the cytochrome P450
(CYP) family. Although P-glycoprotein (Pgp) has been demonstrated to be
coordinately regulated with certain drug-metabolizing enzymes such as
CYP3A4 by a wide array of xenobiotics (Thorgeirsson et al., 1991
;
Schuetz et al., 1996
), the regulation of other drug transporters
including OCTs by xenobiotics or hormones has received little
attention. With the cloning and characterization of the OCTs, it is now
possible to study mechanisms involved in their regulation. Recently,
Urakami et al. (1999
, 2000
) reported that in vivo administration of
testosterone increased the activity and mRNA levels of rOCT2 in the
kidney whereas estradiol moderately reduced it, providing the first
evidence of hormonal regulation of OCTs.
The goals of this study were to 1) identify a cell culture model that can be used to study the functional characteristics and mechanisms involved in the regulation of OCT2, and 2) to elucidate specific mechanisms by which xenobiotics or hormones regulate the activity of OCT2. In the present study, we characterized the localization, kinetics, electrogenicity, and pH dependence of OCT activity in Madin-Darby canine kidney (MDCK) cells. Using RT-PCR and sequence analysis, we determined that OCT2 was likely to be the primary OCT expressed in MDCK cells. Our data suggest that steroid hormones induce the transcription of OCT2 in MDCK cells.
| |
Experimental Procedures |
|---|
|
|
|---|
Materials. Cell culture supplies were purchased from the Cell Culture Facility at the University of California (San Francisco, CA). Original stocks of MDCK cells were obtained from American Type Culture Collection (Manassas, VA). 14C-Tetraethylammonium (14C-TEA) (55 and 2.40 mCi/mmol) was purchased from Moravek Biochemicals (Brea, CA) and PerkinElmer Life Science Products (Boston, MA), respectively. Unlabeled chemicals were supplied by either Sigma (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA). Primers were synthesized by Invitrogen (Carlsbad, CA).
Cell Culture.
MDCK cells (passages 10-40) were grown in
100 × 20 mm plates in minimum Eagle's medium supplemented
with 0.292 g/liter glutamine, 1.0 g/liter glucose, 2.2 g/liter
NaHCO3, 100 IU/ml penicillin, 100 µg/ml
streptomycin, and 10% (v/v) fetal bovine serum. Cells were maintained
at 37°C in a humidified atmosphere (95% air, 5% CO2). Cultures were split 1:10 every 5 days. For
transport studies, cells were polarized by growth on Transwell filters
(0.4-µm pore size, 12-well plate; Costar, Cambridge, MA) at a
confluent density for 7 days with regular media changes as described
elsewhere (Mangravite et al., 2001
).
14C-TEA Uptake Measurements. All uptake experiments were performed on polarized cell monolayers. Briefly, monolayers were washed two times at room temperature in uptake buffer (145 mM NaCl, 3 mM KCl, 1 mM CaCl2, 0.5 mM MgCl2, 5 mM D-glucose, 5 mM HEPES, pH 7.4). Uptake was initiated by application of uptake buffer containing 14C-TEA (with or without inhibitor) to either the apical or basolateral chambers. Blank uptake buffer was added to the opposite side. Although initial experiments showed that the transport rate of 14C-TEA was linear at room temperature for up to 60 min, incubation times of less than 10 min were used for all subsequent experiments to approximate the initial transport rate. Uptake was stopped by aspirating the reaction mixture and washing the filters three times with ice-cold buffer. Membranes were air dried, removed from plastic support, and radioactivity was counted using a Beckman scintillation counter (Beckman Coulter, Inc., Fullerton, CA). Data were normalized to protein count as determined by using the Bio-Rad protein assay (Bio-Rad, Hercules, CA).
Characterization of Endogenous OCT in MDCK Cells.
The OCT in
MDCK cells was functionally localized to the basolateral and/or apical
membrane grossly by uptake measurements. Trans-stimulation
studies were also conducted as described previously (Zhang et al.,
1998b
). Similar to those described previously (Zevin et al., 1998
),
valinomycin (1 µM) dissolved in ethanol was added to the physiologic
buffer (140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 5.0 mM
D-glucose, and 25 mM HEPES) or to a depolarizing buffer (145 mM KCl, 1.8 mM CaCl2, 0.8 mM
MgSO4, 5.0 mM D-glucose, and 25 mM HEPES) to investigate the effect of membrane potential on the
OCT activity. For control cells, an equal amount of ethanol was added
to the uptake medium. To study the effect of pH on OCT activity, the
uptake of 14C-TEA was determined at pH 5.5, 6.5, 7.4, and 8.5, respectively.
Kinetic and Inhibition Studies. Transport kinetics were characterized by measuring uptake of 14C-TEA (5 µM) at 10 min in the presence of varying concentrations of unlabeled TEA (0-500 µM) with or without the OCT inhibitor quinidine (200 µM). The inhibitory effects of selected compounds on OCT activity were also examined by measuring uptake of 14C-TEA in the presence of varying concentrations (0.2-500 µM) of compounds. Data were fit as described under Data Analysis.
RT-PCR and Sequence Analysis.
Total RNA was extracted from
MDCK cells using TRIzol reagent (Invitrogen). For RT-PCR analysis,
1.0-µg total RNA was reverse-transcribed and amplified using
SuperScript one-step RT-PCR with Platinum Taq (Invitrogen) under the
following conditions: 1) initial cycle of 50°C for 30 min and 94°C
for 2 min; 2) 25 to 38 cycles of 94°C for 15 s, 57°C for
30 s and 72°C for 1.5 min; and 3) extension cycle of 72°C for
15 min. Because dog OCT has not been cloned, the OCT primers used in
this study were designed using consensus regions from OCT1, OCT2, or
OCT3 from mammalian species (Table 1).
The mRNA level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in
MDCK cells was also determined as an internal standard for OCT mRNA
quantification. For OCT sequence analysis, 38 PCR cycles were used to
obtain sufficient RT-PCR product. However, the number of PCR cycles for
mRNA quantification was empirically determined with different amounts
of total RNA from the same sample and with the same amount of total RNA
from different samples to ensure that amplification did not reach
saturation and that products would be reflective of mRNA levels in
cells. In most cases, 28 to 33 cycles were optimal for OCT2, whereas 25 to 30 cycles were optimal for GAPDH. ScnImage software (Scion
Corporation, Frederick, MD) was employed to quantify mRNA levels.
|
Regulation Studies.
Regulation was studied by treating
monolayers for 72 h with xenobiotic or hormone prior to uptake of
14C-TEA (50 µM). Compounds were used at a
concentration of 10 µM unless otherwise noted. Controls contained an
equivalent volume of solvent. After 72 h, cells were washed three
times with PBS, and 14C-TEA uptake was measured.
For those compounds with significant effects,
trans-stimulation studies were carried out as described previously (Zhang et al., 1998b
).
Data Analysis. Each data point was determined in duplicate or triplicate for each experiment unless indicated. The data are presented as mean ± standard deviation unless indicated. All experiments were repeated at least once using a different cell passage. To obtain the Km and Vmax in the kinetic studies, the data were fit to the Michaelis-Menten equation: V = Vmax · S/(Km + S), where Vmax is the maximum transport rate, Km is the Michaelis-Menten constant at which the transport rate (V) is one-half the Vmax, and S is the concentration of TEA. Kaleidagraph version 3.0 (Abelbeck/Synergy, Reading, PA) was used to fit the data. IC50 values were estimated by fitting the data to the following equation: V = V0/[1 + (I/IC50)n] where V is the uptake rate of 14C-TEA in the presence of inhibitor, V0 is the uptake rate of 14C-TEA in the absence of inhibitor, I is the concentration of inhibitor, and n is the Hill coefficient. Unpaired Student's t test was applied to analyze data, when appropriate. A p value of <0.05 was considered statistically significant.
| |
Results |
|---|
|
|
|---|
Characterization of Endogenous OCT in MDCK Cells.
The
transport of the model organic cation, TEA, was detectable across both
the basolateral and apical membranes of MDCK cells. However, the uptake
of 14C-TEA was considerably greater across the
basolateral membrane (78.3 ± 7.1 pmol/mg of protein/10 min versus
10.1 ± 2.7 pmol/mg of protein/10 min across the apical membrane,
p < 0.05), and was inhibitable by quinidine (Fig.
1). Basolateral uptake of
14C-TEA was also significantly inhibited by the
organic cations (500 µM) N-methylnicotinamide,
hemicholinium, quinidine, guanidine, cimetidine, and TEA but not by
D-glucose or the organic anion, PAH (Fig.
2). These data suggest that an OCT is
present on the basolateral membrane of MDCK cells.
|
|
|
|
Kinetics of TEA Transport across the Basolateral Membrane of MDCK
Cells.
To determine whether TEA uptake across the basolateral
membrane of MDCK cells was saturable, initial rates (10 min) of
14C-TEA (5 µM) uptake were measured over a
range of TEA concentrations (0-500 µM) (Fig.
5A). Kinetic behavior, evaluated by
Eadie-Hofstee analysis (Fig. 5B), suggests that a single transporter is
involved in the basolateral uptake of TEA into MDCK cells. The
single-component Michaelis-Menten model [V = Vmax · S/(Km + S)] was
then iteratively fit to the untransformed kinetic data, and a good fit
was achieved. Computer modeling derived kinetic parameters were
19.5 ± 4.6 µM (Km) and
350 ± 19.4 pmol/mg of protein/10 min
(Vmax), respectively.
|
RT-PCR and Sequence Analysis. Primers designed to consensus sequences of each OCT were used in RT-PCR to determine which OCT group member was present in MDCK (Table 1). A cDNA fragment was amplified with the primers designed for OCT2. The cDNA fragment was further sequenced as a 711-base pair-long fragment and compared with other published OCT cDNA sequences using BLAST software. The fragment shares at least 83% identity with all the OCT2 cDNA sequences but shares a very low identity (<11%) with those of OCT1 and OCT3, suggesting that a fragment of the canine ortholog of OCT2 had been amplified. This fragment has been reported to GenBank with an accession number of AY028623. No RT-PCR product was detected with the primers designed for OCT1 and OCT3 (data not shown). This suggests that neither OCT1 nor OCT3 are expressed in MDCK cells. Alternatively but less likely, our primers designed to those OCTs of other species may be unable to detect canine OCT1 and OCT3 mRNA in MDCK cells.
Regulation Studies.
We determined whether estradiol and
testosterone as well as several known inducers of drug-metabolizing
enzymes and/or the drug transporter Pgp could regulate the activity and
expression of endogenous OCT2 in MDCK cells. Among the selected drugs
and hormones at the concentration tested, dexamethasone, testosterone, and hydrocortisone significantly enhanced the basolateral
14C-TEA uptake (Fig.
6), whereas estradiol and phenytoin
slightly decreased 14C-TEA uptake by MDCK cells.
Neither a trans-stimulation nor a trans-inhibition effect on 14C-TEA
uptake was observed with these five compounds (data not shown),
excluding trans-effects as a mechanism of their regulatory effects on 14C-TEA uptake. On the other hand,
incubation of cells with phenobarbital, verapamil, rifampicin, thyroid
T3, and metformin for 72 h did not result in any significant
change in 14C-TEA uptake. Dexamethasone,
hydrocortisone, and testosterone increased the basolateral
14C-TEA uptake in a concentration-dependent
manner (Fig. 7). Hydrocortisone (50 µM), which had the most apparent regulatory effect among the three
compounds, more than doubled the 14C-TEA uptake
(180 ± 15 versus 410 ± 0.67 pmol/mg of protein/10 min).
There was no relationship between 14C-TEA uptake
and estradiol concentrations (0.1-10 µM). It was not possible to
determine the concentration-dependent effects of phenytoin on OCT
activity because this compound inhibited proliferation of cells in this
study.
|
|
|
|
| |
Discussion |
|---|
|
|
|---|
In this study, we characterized endogenous OCT activity in MDCK cells, a polarized epithelial cell line derived from canine kidney and examined regulation of this activity by xenobiotics and steroid hormones. Carrier-mediated uptake of TEA was observed on the basolateral membrane (Fig. 1) and was inhibitable by a broad range of organic cations but not by D-glucose, a sugar, or PAH, an organic anion (Fig. 2). This organic cation-specific transport activity was saturable, potential-dependent, and affected by extracellular pH. In addition, TEA uptake could be trans-stimulated by unlabeled TEA and inhibited by preloaded cimetidine or decynium-22 (Fig. 3). These transport properties are characteristic of the OCT group of transporters. Moreover, PCR amplification of cDNA from MDCK cells resulted in a single OCT product, which was at least 83% identical to all reported OCT2 cDNAs, suggesting that the organic cation transport system characterized in MDCK cells may be the canine ortholog of OCT2.
OCTs are thought to localize to the basolateral membrane of epithelial
cells, participating in the first step of a two-part process of cation
transport that results in active secretion of organic cations in the
kidney (Zhang et al., 1998a
). Although there is some evidence to the
contrary (Gorboulev et al., 1997
; Gründemann et al., 1997
),
recent studies using heterologous expression systems and direct
staining of kidney sections with specific antibodies suggest both rOCT1
and rOCT2 are localized to the basolateral membrane (Urakami et al.,
1998
; Sweet and Pritchard, 1999
; Karbach et al., 2000
; Sweet et al.,
2000
). Our data localizing electrogenic OCT activity to the basolateral
membrane of MDCK cells also supports this two-step model of active secretion.
Transport of TEA across the basolateral membrane of MDCK cells was
concentration-dependent and saturable with an apparent Km of 19.5 µM and a
Vmax of 350 pmol/mg of protein/10 min.
This apparent affinity is somewhat higher than those observed for OCT2 homologs of rat, pig, and human (reviewed by Dresser et al., 2001
), suggesting species-related differences in OCT2 characteristics. However, it is possible that other OCT members, which may contribute to
OCT activity in MDCK cells, might not have been detected by the RT-PCR
methods that we used.
Recent studies suggested that the activity and mRNA level of rOCT2 in
rat kidney are increased by testosterone and moderately reduced by
estradiol (Urakami et al., 1999
, 2000
). Consistent with these results,
we observed that both the activity and the mRNA level of OCT2 in MDCK
cells are increased by testosterone and slightly reduced by estradiol.
Furthermore, we observed that the steroid hormones, dexamethasone and
hydrocortisone, also increased OCT2 activity and mRNA level (Fig. 6 and
8). These data suggest that OCT2 can be transcriptionally regulated by
steroid hormones. Hormonal regulation of OCT2 activity may be an
underlying mechanism of the observed gender difference in renal
disposition of amantadine, an organic cation, in humans (Wong et al.,
1995
). MDCK cells have been used for heterologous expression of OCT1
and OCT2 from rat (Urakami et al., 1998
). Our data indicate that MDCK
cells can be used as a convenient model to further study the regulation of OCT2 as well as to screen candidate drugs for interaction with OCT2.
LLC-PK1 cells an original cell line is already available for screening
drugs interacting with OCT2 (Dudley et al., 2000
). However, the OCT2 in
LLC-PK1 cells (OCT2p) is localized to brush membrane (Gründemann
et al., 1997
), which may be different from the basolateral
membrane-located OCT2 in MDCK cells. The OCT2p has been proposed to be
another member of the OCT group (Urakami et al., 1998
). Potential
limitations may still exist when MDCK cell line is used for the above
purposes. For example, this is a cell line with all of the limitations
of cell lines in terms of alteration of function over time in culture.
Moreover, since MDCK cells are derived from the distal tubule of
kidney, the transport mechanisms may be different from those in
proximal tubule cells that are primarily responsible for drug active
secretion in the kidney.
A variety of xenobiotics regulate proteins involved in their
physiologic distribution and/or detoxification, most notably the CYP
family. Because OCTs are important in the active secretion of cationic
xenobiotics, we were interested in examining the potential effect of
several compounds on OCT2 activity and mRNA levels in MDCK cells. We
chose three compounds (phenytoin, dexamethasone, and rifampicin)
documented to coordinately regulate levels of CYP3A4 and Pgp (Schuetz
et al., 1996
), two compounds that are substrates of OCTs (verapamil and
metformin) (Zhang et al., 1998b
; and M. Dresser, G. Xiao, M. Leabman
Kaushal, A. Gray, and K. Giacomini, unpublished data), and
phenobarbital because there is a cis-element for
barbiturate-induced expression in the 5'-upstream region of the human
OCT2 gene (Gründemann and Schömig, 2000
). Of the
non-steroids, only phenytoin affected OCT activity in MDCK cells (Fig.
6). This effect is probably due to the cytotoxic effect of phenytoin
because MDCK cells cultured in medium containing phenytoin (10 µM)
did not proliferate well.
In summary, we have determined that OCT activity in MDCK cells appears to be due to the expression of an OCT2 ortholog. MDCK cells provide a useful tool for examining the transcriptional regulation of OCT2 by xenobiotics and hormones. In this study, we observed that OCT2 in MDCK cells was transcriptionally regulated by steroid hormones.
| |
Footnotes |
|---|
Accepted for publication June 29, 2001.
Received for publication April 27, 2001.
1 Current address: Sugen Inc., 230 East Grand Avenue, South San Francisco, CA 94080-4811.
This work was supported by a Grant GM 36780 from the National Institutes of Health. L.M.M. was also supported by Pharmaceutical Chemistry, Pharmacology and Toxicology Training Grant GM 07175. Y.S. is a recipient of a Merck Sharp & Dohme International Fellowship in Clinical Pharmacology.
Address correspondence to: Dr. Kathleen M. Giacomini, Department of Biopharmaceutical Sciences, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143-0446. E-mail: kmg{at}itsa.ucsf.edu
| |
Abbreviations |
|---|
OCT, organic cation transporter; rOCT, rat organic cation transporter; CYP, cytochrome P-450; Pgp, P-glycoprotein; MDCK, Madin-Darby canine kidney; RT-PCR, reverse transcriptase-polymerase chain reaction; TEA, tetraethylammonium; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PAH, p-aminohippuric acid; PBS, phosphate-buffered saline.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
K. K. Filipski, W. J. Loos, J. Verweij, and A. Sparreboom Interaction of Cisplatin with the Human Organic Cation Transporter 2 Clin. Cancer Res., June 15, 2008; 14(12): 3875 - 3880. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Pelis, R. C. Hartman, S. H. Wright, T. M. Wunz, and C. E. Groves Influence of Estrogen and Xenoestrogens on Basolateral Uptake of Tetraethylammonium by Opossum Kidney Cells in Culture J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 555 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Kang, I.-S. Song, H. J. Shin, W.-Y. Kim, C.-H. Lee, J.-C. Shim, H.-H. Zhou, S. S. Lee, and J.-G. Shin Identification and Functional Characterization of Genetic Variants of Human Organic Cation Transporters in a Korean Population Drug Metab. Dispos., April 1, 2007; 35(4): 667 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gorboulev, N. Shatskaya, C. Volk, and H. Koepsell Subtype-Specific Affinity for Corticosterone of Rat Organic Cation Transporters rOCT1 and rOCT2 Depends on Three Amino Acids within the Substrate Binding Region Mol. Pharmacol., May 1, 2005; 67(5): 1612 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Miakotina, M. Agassandian, L. Shi, D. C. Look, and R. K. Mallampalli Adenovirus stimulates choline efflux by increasing expression of organic cation transporter-2 Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L93 - L102. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wright and W. H. Dantzler Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport Physiol Rev, July 1, 2004; 84(3): 987 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. R. Poola, M. Kalis, F. M. Plakogiannis, and D. R. Taft Characterization of pentamidine excretion in the isolated perfused rat kidney J. Antimicrob. Chemother., September 1, 2003; 52(3): 397 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Pfeil, K. S. Lips, L. Eberling, V. Grau, R. V. Haberberger, and W. Kummer Expression of the High-Affinity Choline Transporter, CHT1, in the Rat Trachea Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 473 - 477. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||